Login / Signup

Dedifferentiated chondrosarcoma: A survival analysis of 159 cases from the SEER database (2001-2011).

Patrick K StrotmanTaylor J ReifStephanie A KliethermesJasmin K SandhuLukas M Nystrom
Published in: Journal of surgical oncology (2017)
The overall prognosis of dedifferentiated chondrosarcoma is poor with a 5-year overall survival of 18%. Patients with a primary tumor located in the chest wall had a better prognosis. Tumors larger than 8 cm, presence of metastases at diagnosis, and treatment without surgical resection were significant predictors of mortality.
Keyphrases
  • free survival
  • cardiovascular events
  • type diabetes
  • risk factors
  • cardiovascular disease
  • coronary artery disease
  • adverse drug
  • electronic health record